Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05134922
Title Expanded Access Protocol for Subjects Previously Treated With Gedatolisib in B2151009
Recruitment Available
Gender female
Phase Expanded access
Variant Requirements No
Sponsors Celcuity, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham AVAILABLE Birmingham Alabama 35233 United States Details
University of Michigan AVAILABLE Ann Arbor Michigan 48109 United States Details
Ohio State University Comprehensive Cancer Center AVAILABLE Columbus Ohio 43210 United States Details
The University of Texas MD Anderson Cancer Center AVAILABLE Houston Texas 77030 United States Details
Seattle Cancer Care Alliance AVAILABLE Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field